Development of Crohn disease during anti-TNF-alpha therapy in a child with juvenile idiopathic arthritis

J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):203-6. doi: 10.1097/00005176-200408000-00016.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Juvenile / drug therapy
  • Child
  • Child, Preschool
  • Crohn Disease / etiology*
  • Crohn Disease / pathology
  • Drug Therapy, Combination
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Male
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / adverse effects*
  • Tumor Necrosis Factor-alpha / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept